RVNC

Revance Therapeutics, Inc.
RVNC

Overview Fund Activity
Delisted

RVNC was delisted on the 5th of February, 2025.

Back to rankings

171 hedge funds and large institutions have $248M invested in Revance Therapeutics, Inc. in 2024 Q4 according to their latest regulatory filings, with 32 funds opening new positions, 60 increasing their positions, 49 reducing their positions, and 59 closing their positions.

Holders
171
Holders Change
-28
Holders Change %
-14.07%
% of All Funds
2.28%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.04%
New
32
Increased
60
Reduced
49
Closed
59
Calls
$15M
Puts
$17.3M
Net Calls
-$2.26M
Net Calls Change
-$1.36M

Top Buyers

1
BCM
1
Beryl Capital Management
California
$18M
2
OBAM
2
ODDO BHF Asset Management
France
$15.5M
3
GCL
3
Glazer Capital LLC
New York
$5.93M
4
NM
4
Newtyn Management
New York
$5.5M
5
Millennium Management
5
Millennium Management
New York
$4.72M

Top Sellers

1
TCM
1
Tang Capital Management
California
$0
2
Franklin Resources
2
Franklin Resources
California
$3.53M
3
KC
3
Kryger Capital
United Kingdom
$0
4
PAI
4
Palo Alto Investors
California
$0
5
MAP
5
Madison Avenue Partners
New York
$0
Name Market Value Shares Shares
Change 		Shares
Change %
BlackRock
1
BlackRock
New York
$26.1M 8,597,418 -130,166 -1%
BCM
2
Beryl Capital Management
California
$18M 5,935,009 +5,935,009 New
Vanguard Group
3
Vanguard Group
Pennsylvania
$17.1M 5,625,091 -108,608 -2%
OBAM
4
ODDO BHF Asset Management
France
$15.5M 5,100,000 +4,375,000 +603%
Fidelity International
5
Fidelity International
Bermuda
$12.8M 4,196,095 +3,162 +0.1%
AllianceBernstein
6
AllianceBernstein
Tennessee
$10.6M 3,497,112 +236,641 +7%
Squarepoint
7
Squarepoint
New York
$9.62M 3,164,943 +855,281 +37%
MF
8
Magnetar Financial
Illinois
$7.77M 2,556,345 +56,174 +2%
State Street
9
State Street
Massachusetts
$7.41M 2,439,140 +5,177 +0.2%
AAM
10
Alpine Associates Management
Florida
$7.14M 2,349,966 -1,812,895 -44%
Geode Capital Management
11
Geode Capital Management
Massachusetts
$6.99M 2,297,582 +7,928 +0.3%
GCL
12
Glazer Capital LLC
New York
$5.93M 1,950,000 +1,950,000 New
NM
13
Newtyn Management
New York
$5.5M 1,810,000 +1,810,000 New
Adage Capital Partners
14
Adage Capital Partners
Massachusetts
$5.03M 1,653,689 +603,689 +57%
Millennium Management
15
Millennium Management
New York
$4.72M 1,551,372 +1,403,562 +950%
UBS Group
16
UBS Group
Switzerland
$4.51M 1,483,040 +850,487 +134%
AA
17
AQR Arbitrage
Connecticut
$4.3M 1,413,103 – –
D.E. Shaw & Co
18
D.E. Shaw & Co
New York
$4.16M 1,367,343 -564,862 -29%
Qube Research & Technologies (QRT)
19
Qube Research & Technologies (QRT)
United Kingdom
$4.04M 1,328,525 -562,736 -30%
JPMorgan Chase & Co
20
JPMorgan Chase & Co
New York
$3.95M 1,298,822 +1,164,641 +868%
GF
21
Gabelli Funds
New York
$3.84M 1,262,487 +171,323 +16%
Franklin Resources
22
Franklin Resources
California
$3.53M 1,161,382 -3,623,276 -76%
CC
23
CIBRA Capital
United Kingdom
$3.47M 1,139,979 +1,139,979 New
GCIA
24
Gabelli & Co Investment Advisers
New York
$3.22M 1,058,500 +218,700 +26%
Northern Trust
25
Northern Trust
Illinois
$3.01M 991,043 +26,248 +3%
1
2 3 4 5